Luai H. Ashari

1.2k total citations
33 papers, 932 citations indexed

About

Luai H. Ashari is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Luai H. Ashari has authored 33 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Luai H. Ashari's work include Colorectal Cancer Surgical Treatments (11 papers), Genetic factors in colorectal cancer (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). Luai H. Ashari is often cited by papers focused on Colorectal Cancer Surgical Treatments (11 papers), Genetic factors in colorectal cancer (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). Luai H. Ashari collaborates with scholars based in Saudi Arabia, Egypt and Australia. Luai H. Ashari's co-authors include Nasser Al‐Sanea, Samar Alhomoud, Alaa Abduljabbar, Fouad Al‐Dayel, Khawla S. Al‐Kuraya, Prashant Bavi, Shahab Uddin, Jehad Abubaker, Maqbool Ahmed and Abdul K. Siraj and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Luai H. Ashari

33 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luai H. Ashari Saudi Arabia 16 443 420 266 209 173 33 932
Rosa Valanzano Italy 20 345 0.8× 514 1.2× 447 1.7× 205 1.0× 177 1.0× 34 1.1k
Isabelle Peyrottes France 18 293 0.7× 263 0.6× 155 0.6× 278 1.3× 170 1.0× 41 901
Shigeto Maeda Japan 18 536 1.2× 535 1.3× 199 0.7× 183 0.9× 299 1.7× 63 1.5k
Anya N. Milne Netherlands 18 365 0.8× 473 1.1× 173 0.7× 161 0.8× 478 2.8× 32 1.1k
Lori S. Tillmans United States 20 386 0.9× 591 1.4× 323 1.2× 288 1.4× 108 0.6× 30 1.2k
Diana L. Hanna United States 17 238 0.5× 600 1.4× 182 0.7× 258 1.2× 164 0.9× 75 1.0k
Sumiko Ohnami Japan 20 734 1.7× 352 0.8× 221 0.8× 402 1.9× 153 0.9× 54 1.3k
Lola Anagnostaki Sweden 18 295 0.7× 435 1.0× 162 0.6× 314 1.5× 101 0.6× 38 861
Irene Thymara Greece 20 574 1.3× 245 0.6× 131 0.5× 269 1.3× 109 0.6× 35 917
Pierre‐Alexandre Just France 17 415 0.9× 269 0.6× 125 0.5× 222 1.1× 163 0.9× 45 1.1k

Countries citing papers authored by Luai H. Ashari

Since Specialization
Citations

This map shows the geographic impact of Luai H. Ashari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luai H. Ashari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luai H. Ashari more than expected).

Fields of papers citing papers by Luai H. Ashari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luai H. Ashari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luai H. Ashari. The network helps show where Luai H. Ashari may publish in the future.

Co-authorship network of co-authors of Luai H. Ashari

This figure shows the co-authorship network connecting the top 25 collaborators of Luai H. Ashari. A scholar is included among the top collaborators of Luai H. Ashari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luai H. Ashari. Luai H. Ashari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bazarbashi, Shouki, Mohammed Neimatallah, Luai H. Ashari, et al.. (2022). Outcome of preoperative concurrent radiation and infusional gemcitabine in locally advanced rectal cancer, a phase 2 trial.. Journal of Clinical Oncology. 40(4_suppl). 94–94. 1 indexed citations
2.
Bazarbashi, Shouki, Alaa Abduljabbar, Luai H. Ashari, et al.. (2022). Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial. Cancer Medicine. 11(10). 2056–2066. 3 indexed citations
3.
Abduljabbar, Alaa, Nasser Al‐Sanea, Samar Alhomoud, et al.. (2022). Retrospective Evaluation of the Impact of Dose Escalation Using Pre-operative Simultaneous Integrated Boost Volumetric Modulated Arc Therapy on the Outcome of Locally Advanced Rectal Cancer Patients. Journal of Gastrointestinal Cancer. 54(3). 927–936. 1 indexed citations
4.
Siraj, Abdul K., Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.. (2019). TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC. Molecular Cancer Therapeutics. 18(7). 1312–1322. 19 indexed citations
5.
Siraj, Abdul K., Sandeep Kumar Parvathareddy, Poyil Pratheeshkumar, et al.. (2019). APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy. Biomedicine & Pharmacotherapy. 121. 109572–109572. 17 indexed citations
6.
Abduljabbar, Alaa, et al.. (2018). Dose Escalation with Simultaneous Integrated Boost (SIB) Using Volumetric Modulated Arc Therapy (VMAT) in Rectal Cancer. Journal of Gastrointestinal Cancer. 50(4). 735–739. 4 indexed citations
7.
Bazarbashi, Shouki, Ahmad Alzahrani, Nasser Al‐Sanea, et al.. (2016). Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer. Hematology/Oncology and Stem Cell Therapy. 9(4). 147–153. 6 indexed citations
8.
Hibbert, Denise, Alaa Abduljabbar, Samar Alhomoud, Luai H. Ashari, & Nasser Al‐Sanea. (2015). Risk Factors for Abdominal Incision Infection after Colorectal Surgery in a Saudi Arabian Population: The Method of Surveillance Matters. Surgical Infections. 16(3). 254–262. 6 indexed citations
9.
Ashari, Luai H., et al.. (2013). Response to Neoadjuvant Chemoradiation in Rectal Cancer: Time to Consider Risk-Adapted Adjuvant Chemotherapy. Annals of Oncology. 24. iv86–iv86. 3 indexed citations
10.
Bavi, Prashant, Shahab Uddin, Maqbool Ahmed, et al.. (2011). Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma. American Journal Of Pathology. 178(5). 2109–2120. 53 indexed citations
11.
Uddin, Shahab, Maqbool Ahmed, Azhar Hussain, et al.. (2011). Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy. American Journal Of Pathology. 178(2). 537–547. 131 indexed citations
12.
Uddin, Shahab, Prashant Bavi, Azhar R. Hussain, et al.. (2009). Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis. 30(11). 1832–1840. 53 indexed citations
13.
Jehan, Zeenath, Prashant Bavi, Mehar Sultana, et al.. (2009). Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. The Journal of Pathology. 219(3). 337–346. 48 indexed citations
14.
Uddin, Shahab, Azhar R. Hussain, Maqbool Ahmed, et al.. (2009). High Prevalence of Fatty Acid Synthase Expression in Colorectal Cancers in Middle Eastern Patients and Its Potential Role as a Therapeutic Target. The American Journal of Gastroenterology. 104(7). 1790–1801. 36 indexed citations
15.
Uddin, Shahab, Maqbool Ahmed, Prashant Bavi, et al.. (2008). Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer. Cancer Research. 68(9). 3379–3388. 66 indexed citations
16.
Uddin, Shahab, Maqbool Ahmed, Prashant Bavi, et al.. (2008). Bortezomib(Velcade) induces p27kip1 associated cell cycle arrest and apoptosis through down-regulation of SKP2 ubiquitin ligase pathway in colorectal carcinoma. Cancer Research. 68. 3265–3265. 1 indexed citations
17.
Abubaker, Jehad, Prashant Bavi, Sayer Al-harbi, et al.. (2008). Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene. 27(25). 3539–3545. 79 indexed citations
18.
Abubaker, Jehad, Prashant Bavi, Sayer Al-harbi, et al.. (2007). Clinicopathological analysis of colorectal cancers withPIK3CA mutations in Middle Eastern population. Molecular Cancer Therapeutics. 6. 1 indexed citations
19.
Ashari, Luai H., John W. Lumley, Andrew R. L. Stevenson, & Russell W. Stitz. (2005). Laparoscopically-Assisted Resection Rectopexy for Rectal Prolapse: Ten Years' Experience. Diseases of the Colon & Rectum. 48(5). 982–987. 47 indexed citations
20.
Ashari, Luai H., et al.. (2003). Portal vein thrombosis following laparoscopic surgery in a patient with sickle cell disease. Surgical Endoscopy. 17(5). 831–831. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026